Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Liabilities and Shareholders Equity (2019 - 2025)

Cresco Labs' Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 11.66% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $5.5 billion, down 9.59%, while the annual FY2025 figure was $1.2 billion, 11.66% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.2 billion in Q4 2025 per CRLBF's latest filing, down from $1.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2021 to a low of $1.2 billion in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 44.45% in 2021, then decreased 14.22% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.8 billion in 2021, then dropped by 11.05% to $1.6 billion in 2022, then fell by 14.22% to $1.4 billion in 2023, then fell by 0.23% to $1.4 billion in 2024, then dropped by 11.66% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Liabilities and Shareholders Equity are $1.2 billion (Q4 2025), $1.4 billion (Q4 2024), and $1.4 billion (Q4 2023).